Intravascular Lithotripsy Market Regional Analysis:
North America Market Insights
North America industry is expected to hold largest revenue share of 35% by 2035. North America has a favorable reimbursement policy for intravascular lithotripsy procedures, which encourages healthcare providers to offer intravenous lithotripsy as a viable treatment option. North America has a highly developed healthcare system and the region is at the forefront of rapid adoption of technological developments. Additionally, an increasing number of people suffering from kidney and cardiac disorders is also driving the growth market in this region during the estimated time period. In the United States one person in every 33 seconds loses their life to cardiac disorder.
Asia Pacific Market Insights
The intravascular lithotripsy market in the Asia Pacific region is estimated to witness a significant market share during the time period between 2025 – 2035. The growth of this market can be primarily driven by the account of increasing awareness about intravascular lithotripsy among the people of this region along with changes in the lifestyle that results in a higher number of people suffering from chronic illness. Furthermore, rising healthcare expenditure in the region is also driving the growth of the market in the APAC region during the projected timeframe.
